查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1224522

mRNA合成材料的市場規模、份額和趨勢分析報告:按類型(封端劑、核甘酸、質粒DNA)、應用、用途、地區、市場預測，2023-2030年

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

mRNA合成材料的市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球 mRNA 合成材料市場預計將達到 33 億美元。 預計從 2023 年到 2030 年，複合年增長率將達到 2.1%。 市場增長的主要驅動力包括學術界和工業界對 mRNA 技術的興趣增加、mRNA 疫苗的優越性以及研究經費的增加。 此外，預計在預測期內，越來越多的 RNA 技術治療應用將為 mRNA 合成材料市場提供有利可圖的機會。

COVID-19 大流行增加了對 mRNA 合成材料的需求，以開發有效的疫苗來對抗傳染病。 mRNA 疫苗是預防 COVID-19 的安全有效方法。 此外，與 mRNA COVID-19 疫苗相關的好處引起了製藥公司在全球範圍內快速提供疫苗的興趣。 例如，2020年3月，美國國家過敏和傳染病研究所與Moderna Co., Ltd.聯合開發了mRNA-1273（NIAID）。 因此，在 COVID-19 大流行期間，mRNA 疫苗的使用量顯著增加。

此外，許多大型製藥公司已開始研究基於 mRNA 的療法，包括 Novartis、Alexion、AstraZeneca、Pfizer、Sanofi Pasteur 和 Shire。 例如，2022 年 1 月，根據輝瑞與 Acuitas Therapeutics 之間的開發和選擇權協議，輝瑞可以選擇許可 Acuitas 的 LNP 技術用於 mRNA 治療和疫苗開發的多達 10 個目標。 因此，製藥和生物技術公司對 mRNA 合成材料的採用率正在提高，進一步推動了市場的增長。

此外，由於 mRNA 的翻譯是瞬時的，並且沒有外來物質摻入細胞的基因組，由此產生的細胞治療產品與傳統方法獲得的產品相比具有許多優勢。這些包括在可接受的製造程序下易於製造、由於靶向和脫靶效應而降低的細胞毒性、臨床驗證和法規適應性。 因此，這些優勢有望增加對 mRNA 療法的需求，進一步推動市場增長。

此外，基於 mRNA 的技術已被證明在治療和預防多種疾病方面具有令人難以置信的前景。 過去十年中技術和科學研究的重大進步使 mRNA 成為一種可行的治療選擇，克服了其較短的半衰期和固有的免疫原性，這些都是一些使用障礙。 例如，隨著 mRNA 技術的進步，與新的過繼性免疫療法的融合可能會帶來更安全、更有效的方法，例如產生最先進的嵌合抗原受體 T 細胞。 因此，預計 mRNA 技術的進步將為市場增長開闢新的途徑。

然而，原材料的高成本可能會在研究期間阻礙市場。 例如，Cleancap AG 等原材料的採購價格約佔兩種疫苗生產過程中原材料總成本的 45%。 此外，圍繞審批程序的監管框架一直是生物技術、製藥和醫療技術行業最重要的抑制因素。 在中國和印度等 mRNA 合成材料市場具有巨大增長潛力的新興國家，由於存在龐大的患者基數，因此缺乏針對治療領域的有效監管框架/指南。預計將阻礙 mRNA 合成材料市場的增長年。

mRNA合成材料市場報告要點

到 2022 年，由於封端技術的進步及其在生物製藥行業和研究中的應用，封端劑部分佔比最大，達到 40.6%

按應用來看，2022年疫苗製造領域佔比高達85.30%。 這歸因於與使用容易失敗的基於細胞培養的生產路線的傳統疫苗相比，mRNA 疫苗的生產速度更快。

到 2022 年，北美將佔據最高的收入份額，達到 35.5%。 這是由於主要參與者的存在、生物技術和製藥公司已建立的商業基礎設施的可用性以及該地區的高研發投資。

從終端用途來看，由於生物製藥領域投資增加，管線增加，對mRNA合成材料的需求增加。2022年，生物製藥和製藥公司領域佔據市場主導地位

目次

第 1 章調查方法及範圍

  • 調查方法
  • 調查假設
  • 資訊採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
  • 資訊或數據分析
    • 數據分析模型
  • 市場制訂和驗證

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章市場變量、趨勢和範圍

  • 母市場分析
  • 市場動態
    • 市場促進因素分析
      • 學術界和工業界對 mRNA 技術的興趣與日俱增
      • mRNA 疫苗的優勢
      • 增加對 mRNA 研究的資助
    • 市場抑制因素分析
      • 沒有針對基於 mRNA 的產品批准的有效政府法規
      • 用於 mRNA 合成的材料成本高
    • 市場問題分析
      • 缺乏經濟實惠的長期製造工藝
  • 描繪採用情況和增長前景
  • mRNA 合成材料市場 - 波特分析
  • mRNA 合成材料市場 SWOT 分析
  • Covid-19 影響分析

第 4 章類型業務分析

  • mRNA 合成材料市場類型變化分析
  • 封蓋劑
  • 核甘酸
  • 質粒DNA
  • 其他

第 5 章應用業務分析

  • mRNA 合成材料市場-應用的變化分析
  • 治療藥物的製造
  • 疫苗生產
  • 其他

第 6 章最終用戶業務分析

  • mRNA 合成材料市場-最終用戶差異分析
  • 生物製藥和製藥公司
  • Cros和Cmos
  • 學術研究機構

第 7 章區域業務分析

  • mRNA 合成材料市場：區域差異分析
  • 北美
    • SWOT 分析
    • 美國
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 加拿大
      • 主要國家動態
      • 競爭場景
      • 監管框架
  • 歐洲
    • SWOT 分析
    • 德國
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 英國
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 法國
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 意大利
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 西班牙
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 丹麥
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 瑞典
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 挪威
      • 主要國家動態
      • 競爭場景
      • 監管框架
  • 亞太地區
    • SWOT 分析
      • 亞太地區 mRNA 合成原材料，2018-2030 年（百萬美元）
    • 日本
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 日本 mRNA 合成材料市場，2018-2030 年（百萬美元）
    • 中國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 2018-2030 年中國 mRNA 合成材料市場（百萬美元）
    • 印度
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 印度 mRNA 合成材料市場，2018-2030 年（百萬美元）
    • 澳大利亞
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 澳大利亞 mRNA 合成材料市場，2018-2030 年（百萬美元）
    • 韓國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 韓國 MRNA 合成材料市場，2018-2030 年（百萬美元）
    • 泰國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 泰國 mRNA 合成材料市場，2018-2030 年（百萬美元）
  • 拉丁美洲
    • SWOT 分析
      • 拉丁美洲 mRNA 合成材料市場，2018-2030 年（百萬美元）
    • 巴西
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 巴西 mRNA 合成材料市場，2018-2030 年（百萬美元）
    • 墨西哥
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 墨西哥 mRNA 合成材料市場，2018-2030 年（百萬美元）
    • 阿根廷
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 阿根廷 mRNA 合成材料市場，2018-2030 年（百萬美元）
  • 中東和非洲
    • SWOT 分析
    • 南非
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 沙特阿拉伯
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 競爭場景
      • 監管框架
    • 科威特
      • 主要國家動態
      • 競爭場景
      • 監管框架

第 8 章競爭格局

  • 參加企業分類
    • F. Hoffmann - La Roche Ltd.
    • Jena Bioscience Gmbh
    • Merck KGaA
    • Yeasen Biotechnology (Shanghai) Co.,Ltd.
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai Lifesciences
    • New England Biolabs
    • Creative Biogene
    • Hongene
  • 財務業績
  • 參賽者分類
    • 市場領導者
      • 2022 年 mRNA 合成原材料市場份額分析
    • 戰略規劃
      • 分機
      • 得到
      • 協作
      • 產品/服務發布
      • 夥伴關係
      • 其他
Product Code: GVR-4-68040-022-4

mRNA Synthesis Raw Materials Market Growth & Trends:

The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.1% from 2023 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights:

  • The capping agents segment held the largest share of 40.6% in 2022 owing to the advancements in the capping technology and their applications in the biopharma industry and research
  • By application, the vaccine production segment captured the highest share of 85.30% in 2022. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that use cell-culture-based production routes, which are often prone to failure
  • North America held the highest revenue share of 35.5% in 2022, due to the presence of key players, the availability of an established commercial infrastructure for biotechnology and pharmaceutical companies, and high research and development investments in the region
  • By end-user, the biopharmaceutical and pharmaceutical companies segment dominated the market in 2022 due to the increasing investments in the biopharmaceutical sector and the rising pipeline, which has boosted the need for mRNA synthesis raw materials

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Parent Market Analysis
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Growing Academic And Industrial Interest In mRNA Technology
      • 3.2.1.2 Advantages Of mRNA Vaccines
      • 3.2.1.3 Increasing Funding For mRNA Research
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Nonexistence Of Effective Government Regulations For mRNA - Based Product Approvals
      • 3.2.2.2 High Cost Of mRNA Synthesis Raw Materials
    • 3.2.3 Market Challange Analysis
      • 3.2.3.1 Lack Of Long - Lasting And Affordable Manufacturing Processes
  • 3.3 Penetration &Growth Prospect Mapping
  • 3.4 mRNA Synthesis Raw Materials Market - Porter's Analysis
  • 3.5 mRNA Synthesis Raw Materials Market - Swot Analysis
  • 3.6 Covid - 19 Impact Analysis

Chapter 4 Type Business Analysis

  • 4.1 mRNA Synthesis Raw Materials Market - Type Movement Analysis
  • 4.2 Capping Agents
    • 4.2.1 Global Capping Agents Market, 2018 - 2030 (USD Million)
  • 4.3 Nucleotides
    • 4.3.1 Global Nucleotides Market, 2018 - 2030 (USD Million)
  • 4.4 Plasmid Dna
    • 4.4.1 Global Plasmid Dna Market, 2018 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Global Other Types Market, 2018 - 2030 (USD Million)

Chapter 5 Application Business Analysis

  • 5.1 mRNA Synthesis Raw Materials Market - Application Movement Analysis
  • 5.2 Therapeutics Production
    • 5.2.1 Global Therapeutics Production Market, 2018 - 2030 (USD Million)
  • 5.3 Vaccine Production
    • 5.3.1 Global Vaccine Production Market, 2018 - 2030 (USD Million)
  • 5.4 Others
    • 5.4.1 Global Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6 End - User Business Analysis

  • 6.1 mRNA Synthesis Raw Materials Market - End User Movement Analysis
  • 6.2 Biopharmaceutical & Pharmaceutical Companies
    • 6.2.1 Global Biopharmaceutical & Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • 6.3 Cros & Cmos
    • 6.3.1 Global Cros & Cmos, 2018 - 2030 (USD Million)
  • 6.4 Academic And Research Institutions
    • 6.4.1 Global Academic And Research Institutions, 2018 - 2030 (USD Million)

Chapter 7 Regional Business Analysis

  • 7.1 mRNA Synthesis Raw Materials Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 Swot Analysis
      • 7.2.1.1 North America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 U.S. mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key country dynamics
      • 7.2.3.2 Competitive scenario
      • 7.2.3.3 Regulatory framework
      • 7.2.3.4 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Swot Analysis
      • 7.3.1.1 Europe mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 Germany mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.3 U.K.
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Uk mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 France mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.5 Italy mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Spain mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Denmark mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Sweden mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Key country dynamics
      • 7.3.9.2 Competitive scenario
      • 7.3.9.3 Regulatory framework
      • 7.3.9.4 Norway mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Swot Analysis
      • 7.4.1.1 Asia Pacific mRNA Synthesis Raw Materials, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 Regulatory Framework
      • 7.4.2.4 Japan mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Regulatory Framework
      • 7.4.3.4 China mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Regulatory Framework
      • 7.4.4.4 India mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Regulatory Framework
      • 7.4.5.4 Australia mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Regulatory Framework
      • 7.4.6.4 South Korea mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Key country dynamics
      • 7.4.7.2 Competitive scenario
      • 7.4.7.3 Regulatory framework
      • 7.4.7.4 Thailand mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Swot Analysis
      • 7.5.1.1 Latin America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Regulatory Framework
      • 7.5.2.4 Brazil mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Regulatory Framework
      • 7.5.3.4 Mexico mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Key country dynamics
      • 7.5.4.2 Competitive scenario
      • 7.5.4.3 Regulatory framework
      • 7.5.4.4 Argentina mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Swot Analysis
      • 7.6.1.1 Mea mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 Key country dynamics
      • 7.6.2.2 Competitive scenario
      • 7.6.2.3 Regulatory framework
      • 7.6.2.4 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key country dynamics
      • 7.6.3.2 Competitive scenario
      • 7.6.3.3 Regulatory framework
      • 7.6.3.4 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 Key country dynamics
      • 7.6.4.2 Competitive scenario
      • 7.6.4.3 Regulatory framework
      • 7.6.4.4 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5 KUWAIT
      • 7.6.5.1 Key country dynamics
      • 7.6.5.2 Competitive scenario
      • 7.6.5.3 Regulatory framework
      • 7.6.5.4 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Participant's Overview
    • 8.1.1 F. Hoffmann - La Roche Ltd.
    • 8.1.2 Jena Bioscience Gmbh
    • 8.1.3 Merck KGaA
    • 8.1.4 Yeasen Biotechnology (Shanghai) Co.,Ltd.
    • 8.1.5 BOC Sciences
    • 8.1.6 Thermo Fisher Scientific, Inc.
    • 8.1.7 Maravai Lifesciences
    • 8.1.8 New England Biolabs
    • 8.1.9 Creative Biogene
    • 8.1.10 Hongene
  • 8.2 Financial Performance
  • 8.3 Participant Categorization
    • 8.3.1 Market Leaders
      • 8.3.1.1 mRNA Synthesis Raw Materials Market Share Analysis, 2022
    • 8.3.2 Strategy Mapping
      • 8.3.2.1 Expansion
      • 8.3.2.2 Acquisition
      • 8.3.2.3 Collaborations
      • 8.3.2.4 Product/service launch
      • 8.3.2.5 Partnerships
      • 8.3.2.6 Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 6 Global mRNA synthesis raw materials market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 11 U.S. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 14 Canada mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 17 Europe mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 21 Germany mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 22 Germany mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 24 U.K. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 25 U.K. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 26 U.K. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 27 France mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 28 France mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 29 France mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 30 Italy mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 31 Italy mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 32 Italy mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 33 Spain mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 34 Spain mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 35 Spain mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 36 Denmark mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 37 Denmark mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 39 Sweden mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 40 Sweden mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 42 Norway mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 43 Norway mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 44 Norway mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 49 Japan mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 50 Japan mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 51 Japan mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 52 China mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 53 China mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 54 China mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 55 India mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 56 India mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 57 India mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 58 South Korea mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 59 South Korea mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Korea mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 61 Australia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 62 Australia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 64 Thailand mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 65 Thailand mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 66 Thailand mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 67 Latin America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 68 Latin America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 69 Latin America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 71 Brazil mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 72 Brazil mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 74 Mexico mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 75 Mexico mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 76 Mexico mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 77 Argentina mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 84 South Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 90 UAE mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 93 Kuwait mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products/services
  • Table 102 Key companies undergoing partnerships
  • Table 103 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2022 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 mRNA synthesis raw materials market: Product outlook and key takeaways
  • Fig. 16 mRNA synthesis raw materials market: Product movement analysis
  • Fig. 17 Global capping agents market, 2018 - 2030 (USD Million)
  • Fig. 18 Global nucleotides market, 2018 - 2030 (USD Million)
  • Fig. 19 Global plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 20 Global other mRNA synthesis raw materials, by type market, 2018 - 2030 (USD Million)
  • Fig. 21 mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 22 mRNA synthesis raw materials market: Application movement analysis
  • Fig. 23 Global therapeutics production market, 2018 - 2030 (USD Million)
  • Fig. 24 Global vaccine production market, 2018 - 2030 (USD Million)
  • Fig. 25 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 26 mRNA synthesis raw materials market: End-use outlook and key takeaways
  • Fig. 27 mRNA synthesis raw materials market: End-use movement analysis
  • Fig. 28 Global biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 29 Global CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 30 Global academic & research institutions market, 2018 - 2030 (USD Million)
  • Fig. 31 mRNA synthesis raw materials market: Regional outlook and key takeaways
  • Fig. 32 North America: SWOT Analysis
  • Fig. 33 North America mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. key country dynamics
  • Fig. 35 U.S. mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe: SWOT Analysis
  • Fig. 39 Europe mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany key country dynamics
  • Fig. 41 Germany mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 France key country dynamics
  • Fig. 43 France mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 U.K. key country dynamics
  • Fig. 45 U.K. mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific: SWOT Analysis
  • Fig. 57 Asia Pacific mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 India key country dynamics
  • Fig. 61 India mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea key country dynamics
  • Fig. 63 South Korea mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Japan key country dynamics
  • Fig. 65 Japan mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Australia key country dynamics
  • Fig. 67 Australia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand key country dynamics
  • Fig. 69 Thailand mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America: SWOT Analysis
  • Fig. 71 Latin America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil key country dynamics
  • Fig. 73 Brazil mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Mexico key country dynamics
  • Fig. 75 Mexico mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina key country dynamics
  • Fig. 77 Argentina mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 MEA: SWOT Analysis
  • Fig. 79 MEA mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa key country dynamics
  • Fig. 81 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia key country dynamics
  • Fig. 83 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 UAE key country dynamics
  • Fig. 85 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait key country dynamics
  • Fig. 87 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Market participant categorization
  • Fig. 89 mRNA synthesis raw materials market share analysis, 2022
  • Fig. 90 Strategy framework